{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:46Z","timestamp":1786119286631,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/wnf.0b013e3181a2b5fd","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T10:39:24Z","timestamp":1253875164000},"page":"301-303","source":"Crossref","is-referenced-by-count":13,"title":["Cutaneous Vasculitis Associated With Interferon \u03b2-1b Treatment for Multiple Sclerosis"],"prefix":"10.1097","volume":"32","author":[{"given":"Jarmila","family":"Szilasiov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Gdovinov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagienka","family":"Jautov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janette","family":"Baloghov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ficov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bohu\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/jnnp.2006.094813","article-title":"Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis.","volume":"77","author":"O'Sullivan","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0151-9638(07)89194-0","article-title":"Panniculitis induced by interferon beta vascular toxicity.","volume":"134","author":"Soria","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2500\/108854188778607200","article-title":"Delayed occurrence of severe cutaneous reaction in a multiple sclerosis patient taking interferon beta-1b.","volume":"19","author":"Cohen","year":"1998","journal-title":"Allergy Asthma Proc"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0889-857X(05)70239-8","article-title":"Drug induced vasculitis.","volume":"27","author":"Merkel","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0560.1984.tb00363.x","article-title":"Lymphocytic vasculitis: is it a special clinicopathologic entity?","volume":"11","author":"Massa","year":"1984","journal-title":"J Cutan Pathol"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1440-0960.2005.00168.x","article-title":"Fixed drug eruption with interferon-beta-1a.","volume":"46","author":"Tai","year":"2005","journal-title":"Australas J Dermatol"},{"key":"R7-14-20210203","first-page":"194","article-title":"Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.","volume":"12","author":"Heinzerling","year":"2002","journal-title":"Eur J Dermatol"},{"key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-3083.2005.01570.x","article-title":"Immunology of cutaneous vasculitis associated with both etanercept and infliximab.","volume":"61","author":"Srivastava","year":"2005","journal-title":"Scand J Immunol"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2340\/00015555577146148","article-title":"Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.","volume":"77","author":"Weinberg","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1191\/1352458503ms933sr","article-title":"Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b.","volume":"9","author":"Casoni","year":"2003","journal-title":"Mult Scler"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WNF.0b013e3181a2b5fd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:58:40Z","timestamp":1786039120000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-200909000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181a2b5fd","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}